Literature DB >> 11032911

Rat alpha-synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex.

M Ghee1, A Fournier, J Mallet.   

Abstract

The alpha-synuclein gene, which encodes a brain presynaptic nerve terminal protein of unknown function, is linked to familial early-onset Parkinson's disease (PD). The finding that alpha-synuclein forms the major fibrillary component of Lewy bodies in brains of PD patients suggests that the two point mutations in alpha-synuclein (Ala(53)Thr, Ala(30)Pro) may promote the aggregation of alpha-synuclein into filaments. To address the role of alpha-synuclein in neurodegenerative diseases, we performed a yeast two-hybrid screen of a rat adult brain cDNA library using rat alpha-synuclein 2 (alphaSYN2). Here we report that alphaSYN2 interacts specifically with Tat binding protein 1, a subunit of the 700-kDa proteasome activator (PA700), the regulatory complex of the 26S proteasome and of the modulator complex, which enhances PA700 activation of the proteasome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032911     DOI: 10.1046/j.1471-4159.2000.0752221.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.

Authors:  L Stefanis; K E Larsen; H J Rideout; D Sulzer; L A Greene
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

Review 2.  The roles of the proteasome pathway in signal transduction and neurodegenerative diseases.

Authors:  Jiao-Jiao Chen; Fang Lin; Zheng-Hong Qin
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

3.  RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability.

Authors:  Dong-Mei Liu; Ling Jin; Hao Wang; Huan-Ying Zhao; Chun-Li Zhao; Hui Yang
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

Review 4.  The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

Authors:  Makoto Hashimoto; Kohichi Kawahara; Pazit Bar-On; Edward Rockenstein; Leslie Crews; Eliezer Masliah
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

Review 5.  Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.

Authors:  Steven H Graham; Hao Liu
Journal:  Ageing Res Rev       Date:  2016-10-01       Impact factor: 10.895

Review 6.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

7.  A cellular model to monitor proteasome dysfunction by alpha-synuclein.

Authors:  Takashi Nonaka; Masato Hasegawa
Journal:  Biochemistry       Date:  2009-08-25       Impact factor: 3.162

Review 8.  Linkage between the proteasome pathway and neurodegenerative diseases and aging.

Authors:  Sophie Vigouroux; Marièle Briand; Yves Briand
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

9.  Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase.

Authors:  Hanock Elkon; Jermy Don; Eldad Melamed; Ilan Ziv; Anat Shirvan; Daniel Offen
Journal:  J Mol Neurosci       Date:  2002-06       Impact factor: 3.444

10.  Reciprocal effects of alpha-synuclein overexpression and proteasome inhibition in neuronal cells and tissue.

Authors:  Melanie Dyllick-Brenzinger; Cheryl A D'Souza; Burkhardt Dahlmann; Peter-Michael Kloetzel; Anurag Tandon
Journal:  Neurotox Res       Date:  2009-08-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.